Yumiko Wada

The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells

Masazumi Nagai, Nha Huu Vo, Luisa Shin Ogawa et al. · Free Radical Biology and Medicine · 2012 · 354 citations

Life Sciences, Oncology, Pharmacology +15

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations

Medicine, Oncology, Pharmacology +11

Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol

Ronald K. Blackman, Kahlin Cheung-Ong, Marinella Gebbia et al. · PLoS ONE · 2012 · 132 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

Jaime Acquaviva, Donald L. Smith, Jim Sang et al. · Molecular Cancer Therapeutics · 2012 · 98 citations

Medicine, Oncology, Pharmacology +14

Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor

Yumiko Wada, Rongzhen Lu, Dan Zhou et al. · Blood · 2006 · 90 citations · Full text

Life Sciences, Immunology, Pharmacology +10